Brooklyn ImmunoTherapeutics (BTX) Competitors $7.67 -0.19 (-2.42%) As of 02/21/2025 03:57 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends BTX vs. ALFIW, and NLOKShould you be buying Brooklyn ImmunoTherapeutics stock or one of its competitors? The main competitors of Brooklyn ImmunoTherapeutics include Alfi (ALFIW), and NortonLifeLock (NLOK). These companies are all part of the "information" sector. Brooklyn ImmunoTherapeutics vs. Alfi NortonLifeLock Brooklyn ImmunoTherapeutics (NYSE:BTX) and Alfi (NASDAQ:ALFIW) are both information companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, community ranking, institutional ownership, valuation, dividends and profitability. Does the media refer more to BTX or ALFIW? In the previous week, Brooklyn ImmunoTherapeutics had 1 more articles in the media than Alfi. MarketBeat recorded 1 mentions for Brooklyn ImmunoTherapeutics and 0 mentions for Alfi. Brooklyn ImmunoTherapeutics' average media sentiment score of 0.00 equaled Alfi'saverage media sentiment score. Company Overall Sentiment Brooklyn ImmunoTherapeutics Neutral Alfi Neutral Does the MarketBeat Community prefer BTX or ALFIW? Brooklyn ImmunoTherapeutics and Alfi both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformBrooklyn ImmunoTherapeuticsOutperform VotesNo VotesUnderperform Votes107100.00% AlfiN/AN/A Which has higher earnings & valuation, BTX or ALFIW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBrooklyn ImmunoTherapeuticsN/AN/AN/A-$2.27-3.38Alfi$200.68KN/AN/AN/AN/A Do institutionals & insiders hold more shares of BTX or ALFIW? 26.0% of Brooklyn ImmunoTherapeutics shares are owned by institutional investors. 20.5% of Brooklyn ImmunoTherapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Is BTX or ALFIW more profitable? Company Net Margins Return on Equity Return on Assets Brooklyn ImmunoTherapeuticsN/A N/A N/A Alfi N/A N/A N/A SummaryBrooklyn ImmunoTherapeutics beats Alfi on 3 of the 4 factors compared between the two stocks. Get Brooklyn ImmunoTherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BTX vs. The Competition Export to ExcelMetricBrooklyn ImmunoTherapeuticsTelevision Broadcasting IndustryInformation SectorNYSE ExchangeMarket Cap$451.20M$451.20M$5.38B$20.34BDividend YieldN/AN/A3.69%3.64%P/E Ratio-3.38N/A8.5328.66Price / SalesN/AN/A5.5415.49Price / CashN/AN/AN/A20.33Price / BookN/AN/AN/A4.80Net IncomeN/AN/AN/A$1.02B7 Day Performance2,565.05%2,565.05%366.08%-1.05%1 Month Performance1,535.74%1,535.74%219.57%-1.09%1 Year Performance376.40%376.40%57.21%13.70% Brooklyn ImmunoTherapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BTXBrooklyn ImmunoTherapeuticsN/A$7.67-2.4%N/A+369.1%$451.20MN/A-3.38N/AAnalyst ForecastALFIWAlfiN/AN/AN/AN/A$0.00$200,684.000.0040NLOKNortonLifeLock0.9072 of 5 stars$27.72-0.6%N/A+26.8%$15.84B$2.82B19.38N/A Related Companies and Tools Related Companies ALFIW Competitors NLOK Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:BTX) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Brooklyn ImmunoTherapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Brooklyn ImmunoTherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
